PIMCO Tactical Income Units Class A T.PTI

Primary Symbol: T.PMEI.UN Alternate Symbol(s): PTIUF

Financial Services Asset Management

PIMCO Dynamic Income Opportunities Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective. The Fund seeks to achieve its investment objectives by utilizing a dynamic asset allocation strategy among multiple fixed income sectors in the global credit markets, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed-, variable- and floating-rate income-producing securities of United States and foreign issuers, including emerging market issuers. The Fund may invest without limitation in investment grade debt obligations and below investment grade debt obligations (high yield securities or junk bonds), including securities of stressed, distressed or defaulted issuers. The Fund's investment manager is Pacific Investment Management Company LLC.

TSX:PMEI.UN - Post by User

PIMCO Tactical Income Units Class A

Bullboard Posts

Comment by mark5698on Nov 23, 2004 9:16am

314 Views

Post# 8213554

RE: Mova Pharmaceutical

The float was small in relation to the average of s&ptsx participants and by the looks of it the company will have ~85 million o/s. So if my read on things is correct we increase the float 55% to more than double earnings Mova is on track to earn between 21 and 22 million for 04 while Patheons is looking at approximately 13.5 million (all in USD). They refinanced the NA debt (hopefully in USD) and they get plants with a lower overall cost base (labour, taxes, etc.) than the company average, I believe. Down side is good will; they will likely write a portion of it down the first chance that they get. Also the increase of debt, but on a comparative basis it looks as if it won't increase substantially. IMHO, it looks good on the surface but the devils in the details and we don't know them all yet. We'll see what the market thinks shortly. Good luck to all

Bullboard Posts

The top 10 Canadian medical stocks